The overarching goal for the Molecular Neuromodulation team is to bring together frontline gene-based technologies with in vivo gene transfer, behavioral and cognitive assessments in disease models of Parkinson’s disease and related disorders for the development of clinical therapies for tomorrow. 

Towards this ultimate goal, the team works along three major areas of research, briefly outlined  in the lnks below.